Education
About Us
Working with TipRanks
Follow Us
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ:HRMY
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 714.73M | $ 582.02M | $ 437.86M | $ 305.44M | $ 159.74M |
| Gross Profit | $ 557.92M | $ 460.79M | $ 354.37M | $ 249.92M | $ 132.00M |
| Operating Income | $ 190.83M | $ 192.03M | $ 120.19M | $ 87.53M | $ 16.99M |
| EBITDA | $ 233.41M | $ 221.51M | $ 146.87M | $ 80.46M | $ 1.51M |
| Net Income | $ 145.49M | $ 128.85M | $ 181.47M | $ 34.60M | $ -36.94M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 467.19M | $ 353.46M | $ 323.12M | $ 234.31M | $ 228.63M |
| Total Assets | $ 999.20M | $ 811.45M | $ 673.87M | $ 433.44M | $ 427.07M |
| Total Debt | $ 181.41M | $ 193.57M | $ 191.65M | $ 195.74M | $ 194.25M |
| Net Debt | $ -271.60M | $ -118.09M | $ -52.14M | $ -38.56M | $ -34.38M |
| Total Liabilities | $ 340.05M | $ 344.46M | $ 271.03M | $ 246.94M | $ 329.89M |
| Stockholders' Equity | $ 659.15M | $ 466.99M | $ 402.84M | $ 186.51M | $ 97.18M |
| Cash Flow | |||||
| Free Cash Flow | $ 218.67M | $ 219.07M | $ 144.29M | $ 98.26M | $ -4.99M |
| Operating Cash Flow | $ 219.82M | $ 219.39M | $ 144.47M | $ 98.56M | $ -2.98M |
| Investing Cash Flow | $ -67.48M | $ -46.44M | $ -141.83M | $ -100.30M | $ -2.00M |
| Financing Cash Flow | $ -11.00M | $ -105.55M | $ 6.84M | $ 7.42M | $ 209.16M |